Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Treatment Options in Urological Cancer

Jonathan Waxman (Herausgeber)

Buch | Hardcover
408 Seiten
2001
Blackwell Science Ltd (Verlag)
978-0-632-05589-0 (ISBN)
CHF 309,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Provides the trainee and practising urologist with a consensus of the management of urological cancer. This title covers each type of cancer (bladder, kidney, testis, prostate and penis) in a dedicated section covering the issues of surgery, drugs, hormone treatment, pathology and molecular biology.
"Treatment Options in Urological Cancer" provides the trainee and practising urologist with an up-to-date consensus of the current management of urological cancer. It does so in a unique way by setting out the opposing arguments in a controversial area of treatment and then providing an expert overview to tease out the key messages. Each type of cancer (bladder, kidney, testis, prostate and penis) is covered in a dedicated section covering the issues of surgery, drugs, hormone treatment, pathology and molecular biology.

Jonathan Waxman is a Professor of Oncology at the Hammersmith Hospital, Imperial College School of Medicine, London. He is a highly experienced clinician who has developed new treatments for cancer, which are now part of standard practice. He is the author of 250 research papers and chapters, and eleven books on cancer.

Contributors. Preface. Part 1: Kidney Caner. 1. The Molecular Biology of Kidney Cancer. (E. P. Castle, G.S. Hallman & J. B. Thrasher) 2. Cytokines and Angiogenesis Inhibitor Treatments. (S. Chowdhury & M. Gore) 3. Surgical Management of Metastatic Renal Cancer. (D. F. Badenoch) Part 2: Bladder Cancer. 4. The Molecular Biology of Bladder Cancer. (P. E. Keegan, D. E, Neal & J. Lunec) 5. Surgery for Advanced Bladder Cancer. (D. W. W. Newling) 6. Chemotherapy and Bladder Cancer. (F. Calabro & C.N. Sternberg) 7. Treatment Options in Superficial (PTa/PT1/CIS) Bladder Cancer. (J. L. Ockrim & P. D. Abel) Part 3: Prostate Cancer. 8. The Molecular Biology of Prostate Cancer. (J. Wang & J Waxman) 9. Surgical Pathology of Prostate Cancer. (C.S. Foster) 10. Prostate Radiotherapy. (C. R. Lewanski & S. Stewart) 11. Prostate Cancer: Immediate vs. Deferred Treatment. (D. Kirk) 12. Hormone Therapy of Prostate cancer. (R. Agarwal & Waxman) 13. Chemotherapy in Hormone Refractory Prostate Cancer. (Leslie E. F. Moffat) 14. Radical Prostatectomy. (T. J. Christmas & A. P. Doherty) 15. The Case against Radical Surgery for Early Prostate Cancer. (Leslie E. F. Moffat) Part 4: Testicular Cancer. 16. Genetics of Adult Male Germ Cell Tumors. (J. Houldsworth, G. J. Bosl & R. S. K. Chaganti) 17. Surveillance, Chemotherapy, and Radiotherapy for Stage 1 Testicular Germ Cell Tumours. (D. H. Palmer & M. H,. Cullen) 18. Chemotherapy of Testicular Cancer. (I. A. Burney & G. M. Mead) 19. Salvage Chemotherapy Regiments of Relapsing Germ Cell Cancer. (M. L. Harvey & G. M. Mead) 20. Surgery for Testicular Cancer. (W. F. Hendry) Part 5: Penile Cancer. 21. Viral Agents in the Development of Penile Cancer. (P. H. Rajjayabun, T. R. L. Griffiths & J. K. Mellon) 22. Current Concepts in the Management of Penile Cancer. (R. Sarin & H. B. Tongaonkar) Index.

Erscheint lt. Verlag 23.11.2001
Verlagsort Oxford
Sprache englisch
Maße 177 x 252 mm
Gewicht 1042 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Urologie
ISBN-10 0-632-05589-8 / 0632055898
ISBN-13 978-0-632-05589-0 / 9780632055890
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95